← Back
$APGE All transactions

Apogee Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$180K

Shares

2,000

Price

$90

Filed

Apr 17

Insider

Name

Henderson Jane

Title

Chief Financial Officer

CIK

0001422304

Roles

Officer

Transaction Details

Transaction Date

2026-04-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

175,371

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.

Filing Info

Accession No.

0001104659-26-045062

Form Type

4

Issuer CIK

0001974640

Henderson Jane's History

Date Ticker Type Value
2026-04-16 APGE $180K
2026-04-01 APGE $76K
2026-04-01 APGE $94K
2026-03-25 APGE $170K
2026-02-02 APGE $52K
2026-02-02 APGE $73K
2026-02-02 APGE $7K
2026-01-06 APGE $160K
2026-01-02 APGE $142K
2026-01-02 APGE $307K

Other Insiders at APGE (90d)

Insider Bought Sold Last
Henderson Jane
Chief Financial Officer
$472K 2026-04-01
HENDERSON MICHAEL THOMAS
Chief Executive Officer
$1.7M 2026-04-16
Dambkowski Carl
Chief Medical Officer
$828K 2026-04-01